Due to an increased risk of heart attack and stroke in patients with cardiovascular disease, sibutramine should not be used in patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.

Sibutramine has been withdrawn in the USA and the European Union due to risk of serious cardiovascular events.